All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

Congress closes synthetic nicotine loophole, ending years of FDA regulatory evasion

By

The editorial unit

7h ago· 5 min readenInsight

Summary

The article discusses the history and implications of synthetic nicotine regulation in the United States. In April 2022, Congress closed a loophole that allowed manufacturers to bypass FDA regulation by using lab-made synthetic nicotine instead of plant-derived nicotine from tobacco. This loophole had enabled companies, particularly those marketing flavored nicotine products appealing to youth, to avoid oversight for years. The article examines the public health impact, the regulatory battle, and the ongoing challenges of enforcement and industry adaptation following the closure of the loophole.

Key quotes

· 3 pulled
In April 2022, Congress closed the synthetic nicotine loophole.
Manufacturers had spent years sidestepping regulation by swapping a plant-derived compound for a lab-built version, and Congress had finally caught on.
This was a rather small but meaningful victory for American public health.
Snippet from the RSS feed
In April 2022, Congress closed the synthetic nicotine loophole. Manufacturers had spent years sidestepping regulation by swapping a plant-derived compound for a lab-built version, and Congress had finally caught on. The loophole was closed with the FDA’s

You might also wanna read